23 Mar 2022 , 01:33 AM
Jubilant Pharmova announced that Jubilant Pharma a material wholly owned subsidiary of the Company through one of its subsidiaries Jubilant Cadista Pharmaceuticals Inc has received Abbreviated New Drug Application ANDA final approval for Doxepin Hydrochloride Capsules 10 mg 25mg 50mg 75mg and 100mg the generic version of Sinequan which is used for the treatment of anxiety depression and other target symptoms of psychoneurosis As on 31 December 2021 Jubilants Pharmaceuticals business had a total of 98 ANDAs for Oral Solids filed in the US of which 61 have been approved and 4 InjectableOpthalmic filings of which 2 have been approved
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
